Dipeptide Repeat Protein Inhibition for Sustainable Agriculture and Environmental Remediation
Legal Citation
Summary of the Inventive Concept
This inventive concept leverages the core technology of Type I PRMT inhibitors to address critical challenges in agriculture, environmental remediation, and ecosystem health, opening up new opportunities for sustainable development.
Background and Problem Solved
The original patent focused on treating neurological disorders such as ALS and FTD. However, the expansion of dipeptide repeat proteins has far-reaching implications beyond human health. In agriculture, fungal infections and pests significantly reduce crop yields, while in environmental remediation, microbial communities struggle to break down pollutants. This inventive concept tackles these pressing issues by applying the Type I PRMT inhibitor technology to novel applications.
Detailed Description of the Inventive Concept
The inventive concept comprises systems and methods for optimizing agricultural crop yields, reducing fungal infections, protecting bee colonies, treating bacterial infections in aquaculture, and improving bioremediation of contaminated soil. In each application, the Type I PRMT inhibitor is administered to inhibit dipeptide repeat proteins, thereby enhancing the health and resilience of targeted organisms. For instance, in agriculture, the inhibitor can be applied to plant cells to boost resistance against fungal pathogens, while in bioremediation, it can be used to stimulate microbial degradation of pollutants.
Novelty and Inventive Step
The new claims introduce a paradigm shift by applying the Type I PRMT inhibitor technology to entirely new industries and fields, thereby creating a novel intersection of biotechnology and environmental sustainability. The inventive concept's novelty lies in its ability to address complex, interconnected challenges in agriculture, ecosystem health, and environmental remediation.
Alternative Embodiments and Variations
Alternative embodiments may include varying the Type I PRMT inhibitor's composition, dosage, or delivery method to suit specific application requirements. Additionally, the inventive concept could be adapted for use in other industries, such as forestry or urban planning, to promote sustainable development and ecosystem resilience.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the agricultural, environmental, and biotechnology sectors. It can help reduce crop losses, enhance ecosystem services, and promote sustainable development, thereby creating new market opportunities and revenue streams for companies operating in these industries.
Original Patent Information
| Patent Number | US 11,857,534 |
|---|---|
| Title | Inhibition of dipeptide repeat proteins |
| Assignee(s) | ALS Therapy Development Institute |